Serum docosahexaenoic acid (DHA) is inversely associated with anxiety disorders in early pregnancy

Journal of Anxiety Disorders

Volumn 30, Issue , 2015, Pages 34-40

  Verly Miguel, Marcus Vinícius Barbosa ^a   Farias, Dayana Rodrigues ^a   Pinto, Thatiana de Jesus Pereira ^a   Lepsch, Jaqueline ^a   Nardi, Antonio Egidio ^a   Kac, Gilberto ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anxiety disorders; Docosahexaenoic acid; Essential fatty acids; Pregnancy

Indexed keywords

DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; BODY MASS; BRAZIL; FEMALE; FIRST TRIMESTER PREGNANCY; GENERALIZED ANXIETY DISORDER; GESTATIONAL AGE; HUMAN; LOWEST INCOME GROUP; MATERNAL BLOOD; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PREGNANT WOMAN; PREVALENCE; ANXIETY DISORDERS; BLOOD; CROSS-SECTIONAL STUDY; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

ADULT; ANXIETY DISORDERS; CROSS-SECTIONAL STUDIES; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; YOUNG ADULT;

EID: 84921025367     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2014.12.002     Document Type: Article

References (34)

1. Almeida M.S., Nunes M.A., Camey S., Pinheiro A.P., Schmidt M.I. Mental disorders in a sample of pregnant women receiving primary health care in Southern Brazil. Cadernos de Saúde Pública 2012, 8:385-393.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Publishing, Arlington, VA. 5th ed.
3. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. American Journal of Clinical Nutrition 2011, 93:950-962.
4. Broekman B.F., Chan Y.H., Chong Y.S., Kwek K., Cohen S.S., Haley C.L., et al. The influence of anxiety and depressive symptoms during pregnancy on birth size. Paediatric and Perinatal Epidemiology 2014, 28:116-126.
5. Buydens-Branchey L., Branchey M. N-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. Journal of Clinical Psychopharmacology 2006, 26:661-665.
6. Cook C.A.L., Flick L.H., Homan S.M., Campbell C., McSweeney M., Gallagher M.E. Psychiatric disorders and treatment in low-income pregnant women. Journal of Women's Health 2010, 19:1251-1262.
7. Fisher J., Mello M.C., Patel V., Rahman A., Tran T., Holton S., et al. Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: A systematic review. Bulletin of the World Health Organization 2012, 90:139-149.
8. Gallagher M.L. The nutrients and their metabolism. Krause's food & nutrition therapy 2008, 39-143. WB Saunders Co, Philadelphia. 12th edn. L.K. Mahan, S. Escott-Stump, L. Raymond (Eds.).
9. Giardinelli L., Innocent A., Benni L., Stefanini M.C., Lino G., Lunardi C., et al. Depression and anxiety in perinatal period: Prevalence and risk factors in an Italian sample. Archives of Women's Mental Health 2012, 15:21-30.
10. Goyens P.L.L., Spilker M.E., Zock L.P., Katan M.B., Mensik R.P. Conversion of a-linolenic acid in humans is influenced by the absolute amounts of a-linolenic acid and linoleic acid in the diet and not by their ratio. American Journal of Clinical Nutrition 2006, 84:44-53.
11. Green P., Hermesh H., Monselise A., Marom S., Presburger G., Weizman A. Red cell membrane omega-3 fatty acids are decreased in non depressed patients with social anxiety disorder. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2005, 16:107-113.
12. Heron J., O'Connor T.G., Evans J., Golding J., Glover J. ALSPAC Study Team. The course of anxiety and depression through pregnancy and the postpartum in a community sample. Journal of Affective Disorders 2004, 80:65-73.
13. Istvan J. Stress, anxiety, and birth outcomes: A critical review of the evidence. Psychological Bulletin 1986, 100:331-348.
14. Johnson R.C., Slade P. Obstetric complications and anxiety during pregnancy: Is there a relationship. Journal of Psychosomatic Obstetrics Gynecology 2003, 24:1-14.
15. Jones J.E. Treating anxiety disorders in children and adolescents with epilepsy: What do we know?. Epilepsy and Behavior 2014, [Epub ahead of print].
16. Kessler R.C., Angermeyer A., Anthony J., Graaf R.D., Demyttenaere K., Gasquet I., et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007, 6:168-176.
17. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 289:3095-3105.
18. Kiecolt-Glaser J.K., Belury M.A., Andridge R., Malarkey W.B., Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain, Behavior, & Immunity 2011, 25:1725-1734.
19. Koletzko B., Cetin I., Brenna J.T., Perinatal Lipid Intake Working Group, Child Health Foundation, Diabetic Pregnancy Study Group, et al. Dietary fat intakes for pregnant and lactating women. British Journal of Nutrition 2007, 98:873-877.
20. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Huth P., Moriarty K., Fishell V., et al. Polyunsaturated fatty acids in the food chain in the United States. American Journal of Clinical Nutrition 2000, 71:179-188.
21. Lepsch J., Vaz J.S., Moreira J.D., Pinto T.J., Soares-Mota M., Kac G. Food frequency questionnaire as an indicator of the serum composition of essential n-3 and n -6 polyunsaturated fatty acids in early pregnancy, according to body mass index. Journal of Human Nutrition and Dietetics 2014, [Epub ahead of print].
22. Lin Y.H., Salem N., Wells E.M., Zhou W., Loewke J.D., Brown J.A., et al. Automated high-throughput fatty acid analysis of umbilical cord serum and application to an epidemiological study. Lipids 2012, 47:527-539.
23. Lohman T.G., Roche A.F., Martorell R. Anthropometric standardization reference manual 1988, Human Kinetics Books, Illinois.
24. Masood A., Stark K.D., Salem N. A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. Journal of Lipid Research 2005, 46:2299-2305.
25. Molyneaux E., Poston L., Ashurst-Williams S., Howard L.M. Obesity and mental disorders during pregnancy and postpartum: A systematic review and meta-analysis. Obstetrics and Gynecology 2014, 123:857-867.
26. Pehlivanidis A., Papanikolaou K., Spyropoulou A.C., Papadimitriou G.N. Comorbid attention-deficit/hyperactivity disorder in adult psychiatric outpatients with depressive or anxiety disorders. International Journal of Psychiatry in Clinical Practice 2014, 1-20. [Epub ahead of print].
27. Qiu C., Williams M.A., Calderon-Margalit R., Cripe S.M., Sorensen T.K. Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy. American Journal of Hypertension 2009, 22:397-402.
28. Santos M.A., Ceretta L.B., Réus G.Z., Abelaira H.M., Jornada L.K., Schwalm M.T., et al. Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: A case-control study. Revista Brasileira de Psiquiatria 2014, [Epub ahead of print].
29. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 1998, 59:22-33.
30. Skodol A.E., Geier T., Grant B.F., Hasi D.S. Personality disorders and the persistence of anxiety disorders in a nationally representative sample. Depression and Anxiety 2014, [Epub ahead of print].
31. Tenkku L.E., Flick L.H., Homan S., Loveland-Cook C.A., Campbell C., McSweeney M. Psychiatric disorders among low-income women and unintended pregnancies. Womens Health Issues 2009, 19:313-324.
32. Torres A.G., Trugo N.M.F. Evidence of inadequate docosahexanoic acid status in Brazilian pregnant and lactating women. Revista de Saúde Pública 2009, 43:359-368.
33. Vaz J.S., Kac G., Emmett P., Davis J.M., Golding J., Hibbeln J.R. Dietary patterns, n-3 fatty acids intake from seafood and high levels of anxiety symptoms during pregnancy: Findings from the Avon Longitudinal Study of Parents and Children. Public Library of Science 2013, 8:e67671.
34. Yehuda S., Rabinovitz S., Mostofsky D.I. Mixture of essential fatty acids lowers test anxiety. Nutritional Neuroscience 2005, 8:265-267.